首页 | 本学科首页   官方微博 | 高级检索  
检索        

长春瑞滨联合顺铂治疗148例晚期非小细胞肺癌疗效观察
引用本文:张长弓,李高峰,向旭东,钱可宝,王巍炜,陈楠,叶联华,郭刚.长春瑞滨联合顺铂治疗148例晚期非小细胞肺癌疗效观察[J].现代医药卫生,2010,26(12):1769-1771.
作者姓名:张长弓  李高峰  向旭东  钱可宝  王巍炜  陈楠  叶联华  郭刚
作者单位:昆明医学院第三附属医院,云南省肿瘤医院胸外科,云南,昆明,650118
摘    要:目的:观察国产长春瑞滨(NVB)联合顺铂(DDP)治疗晚期非小细胞肺癌(NSCLC)的疗效.方法:盖诺25 mg/m2,d1.8;DDP40 mg/m2,d1,2,21~28天为1周期,至少治疗2周期.结果:CR 15例,PR 56例,SD 46例,PD 31例,有效率为44%.不良反应主要为骨髓抑制和消化道反应.结论:NVB加DDP联合化疗治疗晚期NSCLC疗效较高,不良反应可耐受,可作为晚期NSCLC一线治疗方案.

关 键 词:长春瑞滨  顺铂  非小细胞肺癌

Efficacy of vinorelbine plus cisplatin in treatment of 148 cases of advanced non-small cell lung cancer
Institution:ZHANG Chang-gong,LI Gao-feng,XIANG Xu-dong,et al.(Department of Thoracic Surgery,Third Affiliated Hospital,Kunming Medical College,Yunan Provincial Tumor Hospital,Kunming,Yunnan 650118,China)
Abstract:Objective:To observe the effects of domestic vinorelbine(NVB) and cisplatin(DDP) for the treatment of advanced non-small cell lung cancer(NSCLC).Methods:Vinorelbine 25 mg/m2 on 1.8d,PDD 40 mg/m^2 on 1,2d,21~28 d as a cycle,at least two treatment cycles.Results:There were CR in 15 cases,PR in 56 cases,SD in 46 cases and PD in 31 cases with the efficiency of 44%.Toxic side effects were mainly bone marrow suppression and digestive tract reaction.Conclusion:The combination of NVB and DDP in the treatment of advanced NSCLC has a high response rate and tolerable side effects,which can be adopted as the first-line treatment of advanced NSCLC.
Keywords:Vinorelbine  Cisplatin  Non-small Cell lung cancer
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号